Modeling and control to improve blood glucose concentration for people with diabetes

Thumbnail Image
Date
2017-01-01
Authors
Mei, Yong
Major Professor
Advisor
Derrick Rollins
Huaiqing Wu
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
Altmetrics
Authors
Research Projects
Organizational Units
Organizational Unit
Chemical and Biological Engineering

The function of the Department of Chemical and Biological Engineering has been to prepare students for the study and application of chemistry in industry. This focus has included preparation for employment in various industries as well as the development, design, and operation of equipment and processes within industry.Through the CBE Department, Iowa State University is nationally recognized for its initiatives in bioinformatics, biomaterials, bioproducts, metabolic/tissue engineering, multiphase computational fluid dynamics, advanced polymeric materials and nanostructured materials.

History
The Department of Chemical Engineering was founded in 1913 under the Department of Physics and Illuminating Engineering. From 1915 to 1931 it was jointly administered by the Divisions of Industrial Science and Engineering, and from 1931 onward it has been under the Division/College of Engineering. In 1928 it merged with Mining Engineering, and from 1973–1979 it merged with Nuclear Engineering. It became Chemical and Biological Engineering in 2005.

Dates of Existence
1913 - present

Historical Names

  • Department of Chemical Engineering (1913–1928)
  • Department of Chemical and Mining Engineering (1928–1957)
  • Department of Chemical Engineering (1957–1973, 1979–2005)
    • Department of Chemical and Biological Engineering (2005–present)

    Related Units

Journal Issue
Is Version Of
Versions
Series
Department
Chemical and Biological Engineering
Abstract

Diabetes mellitus is a chronical condition that features either the lack of insulin or increased insulin resistance. It is a disorder in the human metabolic system. To combat insufficiency of insulin released by pancreas, a closed-loop control system, also known as artificial pancreas (AP) in this application, have been created to mimic the functionality of a human pancreas. An AP is used to regulate blood glucose concentration (BGC) by managing the release of insulin. Therefore, an algorithm, which can administer insulin to reduce the variation of BGC and minimize the occurrences of hyper-/ hypoglycemia episodes, is the key component of an AP. The objective of the dissertation is to develop an optimal algorithm to better control BGC for people with diabetes.

For people with Type 2 diabetes, prevention or treatment of diabetes mellitus can typically be done via a change of lifestyle and weight management. A virtual sensing system that does not require many manual inputs from patients can ease the burden for people with Type 2 diabetes. This dissertation covers the development of a monitoring system for Type 2 diabetes.

To achieve the goal of tighter control of BGC for people with Type 1 diabetes, dynamic modeling methodology for capturing the cause-and-effect relationship between manipulated variable (i.e. insulin) and controlled variable (i.e. BGC) has been developed. Theoretically, this dissertation has established that physiologically based nonlinear parameterized wiener models being superior to nonlinear autoregressive moving average with exogenous inputs (NARMAX) models in capturing dynamic relationships in processes with correlated inputs. Based on these results, wiener models have been applied in the modeling of BGC for real subjects with Type 1 diabetes under free-living conditions. With promising results shown in wiener models, an extended physiologically based model (i.e. semi-coupled model) has been developed from wiener structure, which enables the development of a phenomenologically sound feedforward control law. The feedforward control law based on wiener models has been tested in simulated continuous-stirred-tank reactor (CSTR) that demonstrates tight control of controlled variables. Further simulation runs with a CSTR also shows feedforward predictive control (FFPC) can provide tighter control over model predictive control (MPC). Lastly, for the special application of BGC control for people with Type 1 diabetes, FFPC demonstrates tighter control than MPC under simulation environment. To account for unmeasured disturbances and inaccurate models for manipulated variable in real life scenarios, feedback predictive control (FBPC) is developed and proven to be a more effective control algorithm under both CSTR and diabetes simulation environment, which can establish the foundation for tightening BGC in real subject clinical studies.

Comments
Description
Keywords
Citation
Source
Copyright
Sun Jan 01 00:00:00 UTC 2017